Document is current
Any future updates will be listed below
-
Authors
Wender, Paul A. https://orcid.org/0000-0001-6319-2829
Gentry, Zachary O.
Fanelli, David J. https://orcid.org/0000-0003-1285-791X
Luu-Nguyen, Quang H. https://orcid.org/0000-0003-3698-5270
McAteer, Owen D. https://orcid.org/0000-0002-8576-6253
Njoo, Edward
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (CA31845)
Foundation for the National Institutes of Health (AI124743)
Foundation for the National Institutes of Health (CA31845)
Foundation for the National Institutes of Health (AI124743)
Foundation for the National Institutes of Health (CA31845)
Foundation for the National Institutes of Health (AI124743)
Foundation for the National Institutes of Health (CA31845)
Foundation for the National Institutes of Health (AI124743)
Foundation for the National Institutes of Health (CA31845)
Foundation for the National Institutes of Health (AI124743)
Foundation for the National Institutes of Health (CA31845)
Foundation for the National Institutes of Health (AI124743)
- License Information
-
More Information
Article History
Received: 26 January 2022
Accepted: 26 August 2022
First Online: 3 October 2022
Competing interests
: A provisional patent application (docket number S21-064) has been filed by Stanford University, on behalf of Paul A. Wender (principal investigator), Zachary O. Gentry, David J. Fanelli, Quang H. Luu-Nguyen, Owen D. McAteer and Edward Njoo, that covers a method to synthesize tigilanol tiglate (EBC-46) and related compounds from readily available starting materials.
